AAAAAA

   
Results: 1-18 |
Results: 18
RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR
Authors: BASSER RL TO LB BEGLEY CG MAHER D JUTTNER C CEBON J MANSFIELD R OLVER I DUGGAN G SZER J COLLINS J SCHWARTZ B MARTY J MENCHACA D SHERIDAN WP FOX RM GREEN MD
Citation: Rl. Basser et al., RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR, Journal of clinical oncology, 16(5), 1998, pp. 1899-1908
PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) INCREASES PLATELET (PLT) COUNT (CT) AND APHERESIS YIELDS OF NORMAL PLT DONORS - INITIAL RESULTS
Authors: GOODNOUGH LT DIPERSIO J MCCULLOUGH J PETERSON R ARMSTRONG S MENCHACA D TOMITA D ROMO J KUTER D
Citation: Lt. Goodnough et al., PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) INCREASES PLATELET (PLT) COUNT (CT) AND APHERESIS YIELDS OF NORMAL PLT DONORS - INITIAL RESULTS, Transfusion, 37(9), 1997, pp. 266-266
EFFECTS OF POLYETHYLENE GLYCOL-CONJUGATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ON PLATELET COUNTS AFTER CHEMOTHERAPY FOR LUNG-CANCER
Authors: FANUCCHI M GLASPY J CRAWFORD J GARST J FIGLIN R SHERIDAN W MENCHACA D TOMITA D OZER H HARKER L
Citation: M. Fanucchi et al., EFFECTS OF POLYETHYLENE GLYCOL-CONJUGATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR ON PLATELET COUNTS AFTER CHEMOTHERAPY FOR LUNG-CANCER, The New England journal of medicine, 336(6), 1997, pp. 404-409
SAFETY AND BIOLOGIC EFFECT OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN BREAST CANTER PATIENTS FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPC)
Authors: BOLWELL B VREDENBURGH J OVERMOYER B GILBERT C CHAP L MENCHACA D SCARLATA D GLASPY J
Citation: B. Bolwell et al., SAFETY AND BIOLOGIC EFFECT OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN BREAST CANTER PATIENTS FOLLOWING AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION (PBPC), Blood, 90(10), 1997, pp. 756-756
TREATMENT OF PLATELET (PLT) DONORS WITH PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) INCREASES CIRCULATING PLT COUNTS (CTS) AND PLT APHERESIS YIELDS AND INCREASES PLATELET INCREMENTS IN RECIPIENTS OF PLT TRANSFUSIONS
Authors: KUTER D MCCULLOUGH J ROMO J DIPERSIO J PETERSON R ARMSTRONG S MENCHACA D TOMITA D GOODNOUGH LT
Citation: D. Kuter et al., TREATMENT OF PLATELET (PLT) DONORS WITH PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) INCREASES CIRCULATING PLT COUNTS (CTS) AND PLT APHERESIS YIELDS AND INCREASES PLATELET INCREMENTS IN RECIPIENTS OF PLT TRANSFUSIONS, Blood, 90(10), 1997, pp. 2579-2579
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)IN BREAST-CANCER PATIENTS (PTS) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT)
Authors: BEVERIDGE R SCHUSTER M WALLER E STUART R ABBOUD C CRUICKSHANK S MENCHACA D MACRI M CONNAGHAN DG
Citation: R. Beveridge et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF)IN BREAST-CANCER PATIENTS (PTS) FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT), Blood, 90(10), 1997, pp. 2580-2580
EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT
Authors: GLASPY J VREDENBURGH J DEMETRI GD CHAP L GILBERT C OVERMOYER B WARREN DL BERG R SCARLATA D MENCHACA D BOLWELL B
Citation: J. Glaspy et al., EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) BEFORE HIGH-DOSE CHEMOTHERAPY (HDC) WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT, Blood, 90(10), 1997, pp. 2582-2582
THROMBOPOIETIC EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN PATIENTS WITH ADVANCED CANCER
Authors: BASSER RL RASKO JEJ CLARKE K CEBON J GREEN MD HUSSEIN S ALT C MENCHACA D TOMITA D MARTY J FOX RM BEGLEY CG
Citation: Rl. Basser et al., THROMBOPOIETIC EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN PATIENTS WITH ADVANCED CANCER, Lancet, 348(9037), 1996, pp. 1279-1281
PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ENHANCES THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY CHEMOTHERAPY AND FILGRASTIM
Authors: BASSER R RASKO J CLARKE K GREEN M CEBON J GRIGG A BERNDT M ZALCBERG J MARTY J MENCHACA D TOMITA D FOX R BEGLEY G
Citation: R. Basser et al., PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ENHANCES THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY CHEMOTHERAPY AND FILGRASTIM, Blood, 88(10), 1996, pp. 2554-2554
RECOMBINANT HUMAN STEM-CELL FACTOR (SCF) (C-KIT LIGAND) PROMOTES MELANOCYTE HYPERPLASIA AND ACTIVATION IN-VIVO
Authors: HARRIST TJ COSTA JJ DEMETRI GD DVORAK AM HAYES DF MERICA EA MENCHACA D GRINGERI AJ GALLI SJ
Citation: Tj. Harrist et al., RECOMBINANT HUMAN STEM-CELL FACTOR (SCF) (C-KIT LIGAND) PROMOTES MELANOCYTE HYPERPLASIA AND ACTIVATION IN-VIVO, Laboratory investigation, 72(1), 1995, pp. 48-48
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ADMINISTERED TO PATIENTS WITH ADVANCED CANCER BEFORE AND AFTER CHEMOTHERAPY - EARLY RESULTS
Authors: BASSER R CLARKE K FOX R GREEN M CEBON J MARTY J MENCHACA D TOMITA D BEGLEY G
Citation: R. Basser et al., RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) ADMINISTERED TO PATIENTS WITH ADVANCED CANCER BEFORE AND AFTER CHEMOTHERAPY - EARLY RESULTS, Blood, 86(10), 1995, pp. 1014-1014
DOSE-RESPONSE OF 7 DAY ADMINISTRATION OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) FOR PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH STAGE II-IV BREAST-CANCER
Authors: GLASPY J LEMAISTRE CF LILL M JONES R MOORE A BRIDDELL R MENCHACA D TURNER S SHPALL EJ
Citation: J. Glaspy et al., DOSE-RESPONSE OF 7 DAY ADMINISTRATION OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (SCF) IN COMBINATION WITH FILGRASTIM (G-CSF) FOR PROGENITOR-CELL MOBILIZATION IN PATIENTS WITH STAGE II-IV BREAST-CANCER, Blood, 86(10), 1995, pp. 1837-1837
MOBILIZATION OF PBPC BY PRIMING WITH STEM-CELL FACTOR (SCF) BEFORE FILGRASTIM COMPARED TO CONCURRENT ADMINISTRATION
Authors: BASSER R BEGLEY CG MANSFIELD R TO B JUTTNER C MAHER D FOX R CEBON J SZER J GRIGG A CLARK K MARTY J MENCHACA D THOMPSON B RUSSELL I COLLINS J GREEN M
Citation: R. Basser et al., MOBILIZATION OF PBPC BY PRIMING WITH STEM-CELL FACTOR (SCF) BEFORE FILGRASTIM COMPARED TO CONCURRENT ADMINISTRATION, Blood, 86(10), 1995, pp. 2734-2734
TREATMENT OF BREAST-CANCER PATIENTS WITH STEM-CELL FACTOR (RHSCF) ANDFILGRASTIM (RHG-CSF) MOBILIZES INCREASED NUMBERS OF MEGAKARYOCYTE PROGENITORS
Authors: BRIDDELL R GLASPY J SHPALL EJ LEMAISTRE F MENCHACA D MCNIECE I
Citation: R. Briddell et al., TREATMENT OF BREAST-CANCER PATIENTS WITH STEM-CELL FACTOR (RHSCF) ANDFILGRASTIM (RHG-CSF) MOBILIZES INCREASED NUMBERS OF MEGAKARYOCYTE PROGENITORS, Experimental hematology, 22(8), 1994, pp. 683-683
PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FROM BREAST-CANCER PATIENTS MOBILIZED WITH STEM-CELL FACTOR (RHSCF) PLUS FILGRASTIM (RHG-CSF) DEMONSTRATE TYPICAL IN-VITRO GROWTH-FACTOR RESPONSIVENESS
Authors: BRIDDELL R STONEY G GLASPY J SHPALL EJ LEMAISTRE F MENCHACA D MCNIECE I
Citation: R. Briddell et al., PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FROM BREAST-CANCER PATIENTS MOBILIZED WITH STEM-CELL FACTOR (RHSCF) PLUS FILGRASTIM (RHG-CSF) DEMONSTRATE TYPICAL IN-VITRO GROWTH-FACTOR RESPONSIVENESS, Experimental hematology, 22(8), 1994, pp. 757-757
RANDOMIZED PROSPECTIVE-STUDY DEMONSTRATING A PROLONGED EFFECT OF SCF WITH G-CSF(FILGRASTIM) ON PBPC IN UNTREATED PATIENTS - EARLY RESULTS
Authors: BEGLEY CG BASSER R MANSFIELD R MAHER D TO B JUTTNER C FOX R CEBON J GRIGG A SZER J MCGRATH K THOMSON B SHERIDAN W MENCHACA D COLLINS J RUSSELL I GREEN M
Citation: Cg. Begley et al., RANDOMIZED PROSPECTIVE-STUDY DEMONSTRATING A PROLONGED EFFECT OF SCF WITH G-CSF(FILGRASTIM) ON PBPC IN UNTREATED PATIENTS - EARLY RESULTS, Blood, 84(10), 1994, pp. 10000025-10000025
CD34-FACTORS PREDICT ENGRAFTMENT POST TRANSPLANTATION( CELLS IN PHERESIS HARVESTS FROM PATIENTS MOBILIZED BY GROWTH)
Authors: MCNIECE I GLASPY J SHPALL EJ LEMAISTRE F MENCHACA D BRIDDELL R
Citation: I. Mcniece et al., CD34-FACTORS PREDICT ENGRAFTMENT POST TRANSPLANTATION( CELLS IN PHERESIS HARVESTS FROM PATIENTS MOBILIZED BY GROWTH), Blood, 84(10), 1994, pp. 10000348-10000348
EFFECTS OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RHG-CSF) ON MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS - PRELIMINARY LABORATORY RESULTS FROM A PHASE-I II STUDY/
Authors: MCNIECE I GLASPY J LEMAISTRE F BRIDDELL R MENCHACA D SHPALL EJ
Citation: I. Mcniece et al., EFFECTS OF RECOMBINANT METHIONYL HUMAN STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RHG-CSF) ON MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS - PRELIMINARY LABORATORY RESULTS FROM A PHASE-I II STUDY/, Blood, 82(10), 1993, pp. 10000084-10000084
Risultati: 1-18 |